|
|
Position:
制剂研发总监或以上 Drug Formulation Director
Employer:
Simcere Pharma Group
Description:
-
Lead the group to meet goal/budget of Simcere R&D formulation platform through streamlining/optimizing the formulation workflow and maximizing the operation efficiency while maintaining full compliance.
-
Supervise the formulation team activities. Provide technical guidance to group leaders and troubleshoot.
-
Supervise preparation for batch records, formulation development reports, and/or other formulation related documents and development plan to ensure high quality and delivered on time.
-
Increase capabilities by building teams and evaluating new valuable technologies/equipment.
-
Develop/build a world-class team of formulation development including planning, recruiting/hiring,
coaching/mentoring, and training to staffs and group leaders.
-
Participate in partnering evaluation activities and provide insights from a formulation perspective.
-
负责建立、领导和管理用于支持公司仿制药、新药产品管线的剂型开发团队
-
通过预算管理,精简、优化配方工作流程,最大限度地提高运营效率,并保证合规
-
计划、协调和科学制定组内员工的工作,并督促项目按期进行,同时为项目组提供必要的技术指导
-
负责批记录的核查,制定发展报告和相关的其他文档制定及流程开发,确保高质量完成工作
-
参与外部合作项目评估,并给予专业意见
Qualifications/Experience:
-
Ph.D. degree or equivalent in Pharmaceutical science or other directly related fields with 8 - 10 years’ experience in the pharmaceutical industry.
-
Excellent impersonal, problem solving and leadership skills.
-
Must be familiar with the requirements of FDA, EMA and CFDA regulations, ICH guidelines and GMP/GLP as well as drug product development process.
-
Experience in generic drug development highly preferred.
-
Must be fluent in Mandarin and English
-
药物制剂专业博士学位,8-10 年以上就职于大型药企或全球研发公司相关专业领域的研发经验,有 仿制药开发经验者或 505(b)2 优先考虑
-
具备优秀的管理能力和团队管理能力,有丰富的大型项目管理经验
-
熟悉 FDA\CFDA 的要求,了解 EMA 和 CFDA 法规、指导方针和 GMP / GLP 以及药物产品开发过程
-
具备很强的解决问题能力和专业技术能力
-
具备良好的沟通和写作能力,普通话和英语流利
Location:
Nanjing or Shanghai, China
Contact:
Chen Chen (chen.chen@simcereusa.com)
Post Date:
11/6/2018 2:17:27 PM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Submit a Text Ad
|